CN103142954A - Medicine for treating asthma - Google Patents
Medicine for treating asthma Download PDFInfo
- Publication number
- CN103142954A CN103142954A CN2013100851216A CN201310085121A CN103142954A CN 103142954 A CN103142954 A CN 103142954A CN 2013100851216 A CN2013100851216 A CN 2013100851216A CN 201310085121 A CN201310085121 A CN 201310085121A CN 103142954 A CN103142954 A CN 103142954A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- fructus
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a medicine for treating asthma; the medicine is prepared from the following materials in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of radix angelicae, 5-15 parts of inula flower, 10-30 parts of cowherb seed, 1-15 parts of herba aristolochiae, 10-20 parts of radices sileris, 15-30 parts of ephedra, 20-30 parts of fructus terminaliae billericae, 1-20 parts of morinda officinalis, 1-20 parts of celandine, 10-25 parts of lalang grass rhizome, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of camuning, 10-20 parts of rainbow conk, 15-20 parts of herba inulae, 15-30 parts of herb of glabrous sarcandra, 10-20 parts of clinopodium polycephalum, 10-25 parts of cortex periplocae, 5-15 parts of aleppo avens, 1-20 parts of herba eupatorii, 15-25 parts of rhododendron dauricum, 15-25 parts of potentilla discolor, 10-20 parts of calyx seu fructus physalis, 15-25 parts of the root bark of white mulberry, 20-30 parts of lindley eupatorium, 1-20 parts of teasel root and 10-25 parts of lily. The components of the medicine provided by the invention for treating asthma are all natural materials, and therefore the medicine is relatively excellent in safety, is exact in curative effect and is suitable for large-scale clinical promotion.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of asthma.
Background technology
Asthma is by the various kinds of cell chronic airway inflammation that participates in of mastocyte, eosinophilic granulocyte and T lymphocyte particularly; This kind inflammation can cause repeatedly the symptoms such as the panting of outbreak, tachypnea, uncomfortable in chest and cough in the susceptible person, how to occur at night or morning; This type of symptom is often limited with extensive and changeable exhalation flow rate, but natural remission or alleviate through treatment partly; This kind symptom also increases multiple stimulating factor reactivity with air flue.In order to solve these miseries, people have carried out a large amount of research, but therapeutic effect is not desirable especially.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of asthma.
in order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of asthma, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Coriolous Dersicolor (Fr.) Quel 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Cortex Periplocae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Herba Eupatorii 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Radix Dipsaci 1-20 part and Bulbus Lilii 10-25 part.
preferably, the medicament for the treatment of asthma of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Coriolous Dersicolor (Fr.) Quel, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Cortex Periplocaes, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Herba Eupatoriis, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Radix Dipsacis and Bulbus Liliies.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for the treatment of asthma of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Further illustrate the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent in the present invention is percetage by weight.
Embodiment decoction of the present invention
take Radix Scrophulariae 7 grams, Rhizoma Zingiberis 13 grams, Fructus Corni 22 grams, Radix Platycodonis 15 grams, the Radix Angelicae Dahuricae 21 grams, Flos Inulae 13 grams, Semen Vaccariae 28 grams, Herba Aristolochiae 11 grams, Radix Saposhnikoviae 17 grams, Herba Ephedrae 24 grams, Fructus Terminaliae Billericae 27 grams, Radix Morindae Officinalis 18 grams, Herba Chelidonii 17 grams, Rhizoma Imperatae 23 grams, Fructus Xanthii 21 grams, Fructus Phyllanthi 16 grams, Folium Et Cacumen Murrayae 16 grams, Coriolous Dersicolor (Fr.) Quel 17 grams, Herba Inulae 19 grams, Herba Sarcandrae 15 grams, Herba Clinopodii 14 grams, Cortex Periplocae 21 grams, Radix seu Herba Gei aleppici 11 grams, Herba Eupatorii 13 grams, Folium Rhododendri Daurici 23 grams, Herba Potentillae Discoloris 24 grams, Calyx Seu Fructus Physalis 14 grams, Cortex Mori 25 grams, Herba Eupatorii Lindleyani 26 grams, Radix Dipsaci 16 grams and Bulbus Lilii 24 grams, add 2000 milliliters of entry, in being housed, heated 4 hours under 80 ℃ by the flask of condensing tube, filter.Filtrate is concentrated into 600 milliliters, namely gets decoction of the present invention.
Experimental example
Diagnostic criteria:
Reference " prevention and control of bronchial asthma guide " (respirology branch of Chinese Medical Association prevention and control of bronchial asthma guide. Chinese tuberculosis and breathing magazine, 1997,20 (5): 261.) Plays, and take the photograph sheet through x-ray, the inspections such as routine blood test are diagnosed as bronchial asthma.Tcm diagnosis meet " new Chinese medicine guideline of clinical investigations " (Ministry of Health of the People's Republic of China. the new Chinese medicine guideline of clinical investigations. the 1st volume. Nanjing: publishing house of Nanjing University, 1994.), card belongs to the hot cooked food lung of expectorant.Clinical manifestation: cough and asthma, the gurgling with sputum sound, the yellow thickness of expectorant, expectorant is not smooth less, and unhappy in the heart, can not crouch night, red tongue yellow and greasy fur, slippery and rapid pulse.
Physical data
Observe case and be the out-patient of the court, totally 60 examples, male 30 examples wherein, female's 30 examples, age 17-54 year, 35.5 years old mean age, the course of disease 3 months-20 years.
Therapeutic Method:
Use the decoction of preparation in embodiment 1, once a day, each serving with 30 milliliters, treated continuously for two weeks.
Efficacy assessment standard:
Recovery from illness: asthma disappears fully, not morbidity more than half a year; Take a turn for the better: asthma obviously alleviates; Invalid: symptom after treatment, sign is without improvement.
Efficacy result:
Find through treatment, recovery from illness 53 examples in 60 patients, 7 examples take a turn for the better.
Claims (3)
1. medicament for the treatment of asthma, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Coriolous Dersicolor (Fr.) Quel 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Cortex Periplocae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Herba Eupatorii 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Radix Dipsaci 1-20 part and Bulbus Lilii 10-25 part.
2. the medicament for the treatment of asthma according to claim 1, it is characterized in that, it is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Coriolous Dersicolor (Fr.) Quel, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Cortex Periplocaes, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Herba Eupatoriis, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Radix Dipsacis and Bulbus Liliies.
3. the medicament for the treatment of asthma according to claim 1, is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013100851216A CN103142954A (en) | 2013-03-18 | 2013-03-18 | Medicine for treating asthma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013100851216A CN103142954A (en) | 2013-03-18 | 2013-03-18 | Medicine for treating asthma |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103142954A true CN103142954A (en) | 2013-06-12 |
Family
ID=48541463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013100851216A Pending CN103142954A (en) | 2013-03-18 | 2013-03-18 | Medicine for treating asthma |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103142954A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103550459A (en) * | 2013-11-05 | 2014-02-05 | 张士香 | Preparation method of medicament for treating infantile asthma |
CN103550545A (en) * | 2013-10-23 | 2014-02-05 | 陈英娣 | Traditional Chinese medicine for treating cardiac asthma |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100998745A (en) * | 2006-12-26 | 2007-07-18 | 章丽美 | Oral traditional Chinese medicine for treating asthma of deficiency of yin |
CN101028507A (en) * | 2007-02-26 | 2007-09-05 | 赵红霞 | Chinese-medicinal composition for treating asthma |
CN102416152A (en) * | 2011-12-07 | 2012-04-18 | 黄炳炎 | Medicament for treating asthma |
CN102600336A (en) * | 2012-03-31 | 2012-07-25 | 王品 | Medicament for treating asthma |
-
2013
- 2013-03-18 CN CN2013100851216A patent/CN103142954A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100998745A (en) * | 2006-12-26 | 2007-07-18 | 章丽美 | Oral traditional Chinese medicine for treating asthma of deficiency of yin |
CN101028507A (en) * | 2007-02-26 | 2007-09-05 | 赵红霞 | Chinese-medicinal composition for treating asthma |
CN102416152A (en) * | 2011-12-07 | 2012-04-18 | 黄炳炎 | Medicament for treating asthma |
CN102600336A (en) * | 2012-03-31 | 2012-07-25 | 王品 | Medicament for treating asthma |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103550545A (en) * | 2013-10-23 | 2014-02-05 | 陈英娣 | Traditional Chinese medicine for treating cardiac asthma |
CN103550545B (en) * | 2013-10-23 | 2016-01-20 | 朱军 | A kind of Chinese medicine for the treatment of cardiac asthma |
CN103550459A (en) * | 2013-11-05 | 2014-02-05 | 张士香 | Preparation method of medicament for treating infantile asthma |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102058767B (en) | Chinese medicine for treating senile chronic bronchitis and method for preparing pills thereof | |
CN105663532A (en) | Traditional Chinese medicine composition for treating henpox | |
CN104940485A (en) | Traditional Chinese medicine composition for treating infantile asthma and preparation method thereof | |
CN106075029B (en) | A kind of prevention and treatment chicken defends the traditional Chinese medicine oral liquid of Qi phase syndrome | |
CN102552509B (en) | Traditional Chinese medicine combination for reducing heat and relieving cough | |
CN102416152B (en) | Medicament for treating asthma | |
CN103142954A (en) | Medicine for treating asthma | |
CN105941755A (en) | Dendrobium officinale healthcare tea capable of removing internal heat and decreasing blood lipid and preparation method thereof | |
CN102139051A (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
CN103893601B (en) | A kind of medicament for the treatment of mumps | |
CN105395941A (en) | A heat clearing and detoxifying traditional Chinese medicine oral liquid | |
CN103191385B (en) | Medicament for treating infantile asthma | |
CN103405722B (en) | Chinese herba preparation for preventing and treating infantile cough | |
CN104524256A (en) | Traditional Chinese medicine for treating viral pneumonia | |
CN103610932A (en) | Medicament for treating urinary calculus | |
CN103816430A (en) | Traditional Chinese medicinal composition for treating asthma, and preparation method thereof | |
CN103301368A (en) | Medicament for treating hyperactivity | |
CN102755566B (en) | Medicament for treating bronchial asthma | |
CN103610845B (en) | Preparation method for medicine for treating chronic cough of children | |
CN103100013B (en) | Traditional Chinese medicine decoction for treating bronchiectasis | |
CN106237061A (en) | A kind of Chinese medicine formula of clearing away lung-heat to relieve cough yin nourishing | |
CN103142980A (en) | Medicament for treating infantile cough | |
CN105362548A (en) | Traditional Chinese medicine for treating allergic asthma | |
CN103845710A (en) | Traditional Chinese medicine for treating intestinal ascariasis | |
CN104491378A (en) | Method for preparing medicine for treating bronchial asthma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130612 |